Posted 1/16/2014 7:07 PM (GMT 0)
just scanned the article to see how this differed from existing research with bone-marrow and adipose-tissue stem cells for IBD. my stem-cell knowledge is shaky, but if I understand these stem cells use colon tissue, and would be more similar to the prior research on adipose-tissue stem cells rather than bone-marrow.
anyway, these cells seem to repair crypt cells in mucosa rater than repairing immune system cells (like bone-marrow aka hemipotent stem cells do).
if I am following however, the idea is to take an individual's cells, induce the pluripotent stem cell status, and provide "patient specific" stem cell treatment. I think the current research, both bone-marrow and adipose tissue, use cells from many donors to make a non-patient-specific stem cell product (for example MULTISTEM).
anyway, I think the "advance" is the patient-specific dimension.